Physician profile
Phillip Saunders
NPI 1144578683
$21,153.47
in general payments reported to CMS, 2019-2025
84 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $2,661 · 2021: $4,611 · 2022: $3,887 · 2023: $3,778 · 2024: $4,025 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,553 · Long Term Medical Supply Or Device Loan: $1,083 · Education: $16.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,552.74 |
| Long Term Medical Supply Or Device Loan | $1,083.29 |
| Education | $16.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,123.65 | 2019-2025 | |
| Janssen Biotech, INC. | $1,221.82 | 2019-2025 | Erleada, Carvykti, Talvey |
| Astrazeneca Pharmaceuticals Lp | $1,162.36 | 2019-2025 | Lynparza, Calquence, Tagrisso |
| Incyte Corporation | $989.65 | 2020-2025 | Jakafi, Monjuvi, Zynyz |
| E.R. Squibb & Sons, L.L.C. | $850.28 | 2019-2025 | Reblozyl, Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $718.02 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $678.80 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $676.65 | 2020-2023 | Imbruvica, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $636.72 | 2019-2025 | Alunbrig, Fruzaqla, Iclusig |
| Celgene Corporation | $622.43 | 2020-2025 | Pomalyst, Reblozyl, Opdualag |
| Regeneron Healthcare Solutions, INC. | $464.22 | 2020-2025 | Libtayo |
| Eisai INC. | $408.58 | 2021-2025 | |
| Seagen INC. | $399.63 | 2020-2023 | Adcetris, Padcev |
| Amgen INC. | $383.53 | 2020-2023 | Lumakras |
| Lilly USA, LLC | $369.17 | 2020-2025 | Jaypirca, Verzenio, Retevmo |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $335.01 | 2020-2025 | |
| Astellas Pharma US INC | $321.09 | 2020-2025 | Xtandi, Padcev, Xospata |
| Glaxosmithkline, LLC. | $302.83 | 2020-2025 | Ojjaara, Shingrix |
| Abbvie INC. | $292.33 | 2020-2025 | |
| Genzyme Corporation | $291.11 | 2020-2025 | |
| Array Biopharma INC | $260.97 | 2020-2025 | Braftovi, Mektovi, Tukysa |
| Kite Pharma, INC. | $255.56 | 2020-2025 | Yescarta |
| Blueprint Medicines Corporation | $244.73 | 2020-2025 | Ayvakit |
| Stemline Therapeutics INC. | $237.25 | 2020-2025 | Orserdu, Elzonris |
| Genentech USA, INC. | $234.26 | 2020-2025 | Tecentriq, Itovebi, Venclexta |
| Puma Biotechnology, INC. | $223.59 | 2020-2024 | |
| Beigene USA, INC. | $220.47 | 2021-2024 | Brukinsa |
| Rigel Pharmaceuticals, INC. | $213.66 | 2020-2024 | Tavalisse, Rezlidhia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.68 | 2020-2022 | |
| Dova Pharmaceuticals | $203.71 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $180.38 | 2020-2024 | Onivyde, Somatuline Depot, Tazverik |
| Sobi, INC | $162.79 | 2021-2024 | |
| Emd Serono, INC. | $160.24 | 2020-2024 | Bavencio |
| Dendreon Pharmaceuticals LLC | $155.06 | 2019-2025 | Provenge |
| Daiichi Sankyo INC. | $143.41 | 2020-2024 | Enhertu |
| Eusa Pharma (US) LLC | $137.88 | 2021-2022 | |
| Tempus Ai, INC | $131.63 | 2024-2025 | Xt Cdx |
| Taiho Oncology, INC. | $126.23 | 2020-2022 | |
| Agios Pharmaceuticals, INC. | $120.51 | 2019-2025 | Pyrukynd |
| Foundation Medicine, INC. | $118.32 | 2020-2023 | Foundationone Cdx |
| Gilead Sciences, INC. | $112.93 | 2019-2025 | Trodelvy |
| Deciphera Pharmaceuticals INC. | $112.32 | 2021-2024 | Qinlock |
| Epizyme, INC. | $109.09 | 2020-2022 | |
| Csl Behring | $105.14 | 2020-2022 | |
| Karyopharm Therapeutics INC. | $102.38 | 2020-2022 | |
| Mirati Therapeutics, INC. | $96.16 | 2023-2024 | Krazati |
| Exelixis INC. | $86.42 | 2019-2025 | Cabometyx |
| Tersera Therapeutics LLC | $84.10 | 2021-2025 | Quzyttir, Zoladex |
| Adc Therapeutics America, INC. | $76.42 | 2022-2025 | |
| Verastem, INC. | $72.57 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $72.33 | 2022-2024 | Pylarify |
| Recordati_rare_diseases_inc. | $72.03 | 2023-2025 | Sylvant, Enjaymo |
| Morphosys, US INC. | $70.92 | 2022-2023 | Monjuvi |
| Alexion Pharmaceuticals, INC. | $69.68 | 2020-2024 | Ultomiris |
| Ge Healthcare | $62.97 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $60.52 | 2022-2025 | Monoferric |
| Octapharma USA, INC. | $56.54 | 2021 | |
| Jazz Pharmaceuticals INC. | $54.22 | 2024-2025 | |
| Cti Biopharma Corp. | $47.02 | 2022-2023 | Vonjo |
| Adaptive Biotechnologies Corporation | $40.76 | 2022 | |
| Myriad Genetic Laboratories, INC. | $39.83 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $37.26 | 2020-2022 | |
| Caris Mpi, INC. | $36.14 | 2025 | Mi Cancer Seek |
| Sirtex Medical INC | $35.27 | 2024 | Sir-Spheres Microspheres |
| Coherus Oncology, INC. | $35.05 | 2025 | Loqtorzi |
| Cumberland Pharmaceuticals, INC. | $31.73 | 2024 | Sancuso |
| Geron Corporation | $30.03 | 2025 | Rytelo |
| Apellis Pharmaceuticals, INC. | $29.09 | 2023 | Empaveli |
| Springworks Therapeutics, INC. | $28.12 | 2025 | Ogsiveo |
| Alnylam Pharmaceuticals INC. | $26.19 | 2021 | |
| Clovis Oncology, INC. | $25.00 | 2020 | |
| Servier Pharmaceuticals LLC | $24.78 | 2024 | |
| Pharmaessentia USA Corporation | $24.66 | 2025 | Besremi |
| Immunocore Limited | $24.08 | 2024 | Kimmtrak |
| Immunogen, INC. | $23.80 | 2023 | Elahere |
| G1 Therapeutics, INC. | $21.62 | 2023 | Cosela |
| Sumitomo Pharma America, INC. | $21.02 | 2024 | Orgovyx |
| Iovance Biotherapeutics, INC. | $19.54 | 2025 | Amtagvi |
| Aveo Pharmaceuticals, INC. | $16.27 | 2025 | |
| Telix Pharmaceuticals | $15.98 | 2023 | Illuccix |
| Secura Bio, INC. | $15.52 | 2021 | |
| Fennec Pharmaceuticals, INC. | $14.36 | 2025 | Fyarro |
| Acrotech Biopharma INC. | $14.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.11 | 2020 |
Drugs and devices associated with these payments
Kisqali $1,179Imbruvica $473Keytruda $367Lenvima $360Jakafi $332Libtayo $321Lynparza $271Scemblix $251Welireg $229Orserdu $194Padcev $186Reblozyl $186Piqray $172Erleada $163Enhertu $149Pomalyst $143Tavalisse $142Rezlidhia $142Tukysa $138Stivarga $129Vitrakvi $129Mektovi $128Braftovi $128Xtandi $128Opdualag $127Adcetris $126Ayvakit $126Alunbrig $122Jaypirca $115Epkinly $107Ibrance $103Opdivo $102Verzenio $99.89Doptelet $97.33Krazati $96.16Monjuvi $94.09Carvykti $93.99Fruzaqla $86.16Talvey $84.62Tecvayli $84.62Akeega $84.11Yescarta $82.35Calquence $81.66Pyrukynd $76.80Retevmo $75.50Ojjaara $74.00Darzalex $73.80Tagrisso $73.18Mekinist $72.34Cabometyx $70.02Qinlock $68.19Somatuline Depot $68.13Onivyde $68.13Lorbrena $63.97Trodelvy $62.03Elahere $60.96Rybrevant $58.66Orgovyx $58.61Balversa $58.17Provenge $58.15Fabhalta $56.35Zepzelca $54.22Pylarify $52.49Nubeqa $50.21Pluvicto $49.79Keytruda Qlex $49.77Xt Cdx $48.43Tazverik $48.23Xospata $47.42Sylvant $46.91Tecentriq $46.13Xalkori $45.78Imfinzi $43.11Lutathera $39.24Elrexfio $38.90Talzenna $37.59Itovebi $36.78Mi Cancer Seek $36.14Sir-Spheres Microspheres $35.27Loqtorzi $35.05Ultomiris $33.44Synagis $32.49Illuccix $31.96Sancuso $31.73Iclusig $30.25Rytelo $30.03Empaveli $29.09Paxlovid $28.90Lumakras $28.37Ogsiveo $28.12Venclexta $27.78Zynyz $26.71Elzonris $26.56Vyloy $25.96Enjaymo $25.12Tibsovo $24.78Zynlonta $24.72Besremi $24.66Phesgo $24.58Kimmtrak $24.08
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.